![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of 10mg (high-dose) bulevirtide (Myrcludex B) in combination with PEG-IFNa or TDF in patients with chronic HBV/HDV co-infection:
interim results.
|
|
|
AASLD 2019 Nov 8-11 Boston
Heiner Wedemeyer,
Katrin Schoneweis, Pavel Bogomolov, Natalia Voronkova, Vladimir Chulanov, Tatyana Stepanova, Lena Allweiss, Maura Dandri, Sandra Ciesek, Ulf Dittmer, Walter E. Haefeli, Alexander Alexandrov, Stephan Urban
![1205191](../images/120619/120619-1/1205191.gif)
![1205192](../images/120619/120619-1/1205192.gif)
![1205193](../images/120619/120619-1/1205193.gif)
![1205194](../images/120619/120619-1/1205194.gif)
![1205195](../images/120619/120619-1/1205195.gif)
![1205196](../images/120619/120619-1/1205196.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|